secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2025-12-18T23:59:59+00:00
Accession:  0001062993-25-017390
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed shareholders re-elect all five directors, approve auditor and share issuance at AGM
--------------------------------------------------------------------------------

- All five director nominees elected with 81.9% to 82.1% support.
- Appointment of CBIZ CPAs P.C. as auditor for 2026 approved (78.8% for).
- Shareholders approved potential issuance of >=20% of shares under SEPA with YA II PN (65.9% for).
- Turnout was 993,491 shares (35.43% of outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000106299325017390/0001062993-25-017390-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000106299325017390/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-25-017390

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer